With Novo CEO on the hot seat at Senate hearing, PBMs and insurance concerns get the spotlight
Fierce Pharma
SEPTEMBER 24, 2024
drug prices, the role of insurers and pharmacy benefit managers (PBMs) often commands at least some of the attention. | At the Senate committee hearing on Novo Nordisk's prices for Ozempic and Wegovy, debate around insurance coverage and pharmacy benefit managers took up much of the conversation.
Let's personalize your content